Losmiprofen
- Level
- Commodity
- Parent
- 51384500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51384512This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C17H15ClO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GRY6X9550R, chemically known as propionic acid, 2-(3-(p-chlorobenzoyl)-o-tolyloxy)- but generally known as losmiprofen, which bears US NIH Compound Identifier 68922. European Medicines Agency schedules Losmiprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08596MIG. The term LOSMIPROFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). LOSMIPROFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule losmiprofen under HS 29189900 and SITC 51396. As of Q4 2014, LOSMIPROFEN remains the US FDA Preferred Term for this commodity. Losmiprofen bears US NLM identifiers UMLS ID C2825255 and NCI Concept Code C80562. SMILES: CLC1CCC(C(=O)C2C(C(OC(C)C(=O)O)CCC2)C)CC1.
Same parent
Under 51384500 · 34Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.